Amgen (AMGN)
437.23
-6.89 (1.55%)
Upcoming Events
Latest Headlines
Amgen (AMGN) PT Raised to $435 at Wells Fargo
September 4, 2026 5:27 AM - StreetInsider
Amgen (AMGN) call put ratio 1 call to 1.1 puts
August 31, 2026 5:47 AM - StreetInsider
Amgen's Tezspire meets all endpoints in phase 3 esophagitis trial
August 27, 2026 2:00 AM - StreetInsider
TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
August 27, 2026 2:00 AM - PR NewsWire
FTC files amicus brief challenging Amgen's Enbrel patent acquisition
August 21, 2026 11:58 AM - StreetInsider
Amgen (AMGN) PT Raised to $457 at Piper Sandler
August 20, 2026 7:22 AM - StreetInsider
Amgen (AMGN) PT Raised to $362 at Morgan Stanley
August 19, 2026 9:07 AM - StreetInsider
Amgen (AMGN) PT Raised to $460 at Argus
August 19, 2026 7:24 AM - StreetInsider
Amgen (AMGN) PT Raised to $400 at Cantor Fitzgerald on Higher Sales Estimates
August 18, 2026 8:52 AM - StreetInsider
Amgen (AMGN) PT Raised to $352 at Mizuho
August 18, 2026 6:36 AM - StreetInsider
Amgen (AMGN) PT Raised to $380 at Barclays
August 14, 2026 4:20 AM - StreetInsider
Form 4 AMGEN INC For: Aug 11 Filed by: Khosla Rachna
August 13, 2026 7:06 PM - SEC Filing
Form 144 AMGEN INC Filed by: Khosla Rachna
August 13, 2026 11:14 AM - SEC Filing
Form 4 AMGEN INC For: Aug 07 Filed by: Busch Matthew C.
August 12, 2026 8:05 PM - SEC Filing
Form 144 AMGEN INC Filed by: Khosla Rachna
August 11, 2026 3:41 PM - SEC Filing
Form 4 AMGEN INC For: Aug 07 Filed by: ISHRAK OMAR
August 10, 2026 8:24 PM - SEC Filing
Form 4 AMGEN INC For: Aug 07 Filed by: HOLLEY CHARLES M
August 10, 2026 8:22 PM - SEC Filing
Form 4 AMGEN INC For: Aug 07 Filed by: Drake Michael V
August 10, 2026 8:20 PM - SEC Filing
Amgen (AMGN) PT Raised to $388 at Guggenheim
August 10, 2026 7:28 AM - StreetInsider
Form 4 AMGEN INC For: Aug 06 Filed by: Miller Derek
August 7, 2026 6:47 PM - SEC Filing
Form 4 AMGEN INC For: Aug 06 Filed by: Grygiel Nancy A.
August 7, 2026 6:46 PM - SEC Filing
Morgan Stanley tracks US drug market prescriptions for week ending July 31
August 7, 2026 12:04 PM - StreetInsider
Form 144 AMGEN INC Filed by: Miller Derek
August 6, 2026 5:10 PM - SEC Filing
Form 144/A AMGEN INC Filed by: Grygiel Nancy A.
August 6, 2026 3:17 PM - SEC Filing
Form 144 AMGEN INC Filed by: Grygiel Nancy A.
August 6, 2026 2:13 PM - SEC Filing
Amgen (AMGN) PT Raised to $345 at Bernstein SocGen Group
August 6, 2026 9:24 AM - StreetInsider
Amgen (AMGN) PT Raised to $440 at UBS
August 5, 2026 8:54 AM - StreetInsider
Amgen (AMGN) PT Raised to $452 at TD Cowen
August 5, 2026 8:11 AM - StreetInsider
Amgen (AMGN) PT Raised to $400 at Wells Fargo
August 5, 2026 7:56 AM - StreetInsider
Amgen (AMGN) PT Raised to $400 at RBC Capital After an 'Impressive Q'
August 5, 2026 7:44 AM - StreetInsider
Amgen (AMGN) PT Raised to $450 at BMO Capital
August 5, 2026 7:11 AM - StreetInsider
Form 10-Q AMGEN INC For: Jun 30
August 5, 2026 6:02 AM - SEC Filing
Amgen (AMGN) Tops Q2 EPS by 69c, Beats on Revenue; Offers FY26 Guidance
August 4, 2026 4:04 PM - StreetInsider
Form 8-K AMGEN INC For: Aug 04
August 4, 2026 4:04 PM - SEC Filing
AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
August 4, 2026 4:01 PM - PR NewsWire
Amgen (AMGN) call put ratio 1.1 calls to 1 put into quarter results
August 4, 2026 10:46 AM - StreetInsider
Amgen (AMGN) call put ratio 1 call to 2 puts into quarter results
August 3, 2026 10:32 AM - StreetInsider
Amgen (AMGN) call put ratio 2.4 calls to 1 put into quarter results
August 3, 2026 6:05 AM - StreetInsider
U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
August 1, 2026 10:00 AM - StreetInsider
Amgen reports data breach involving patient and proprietary data
July 31, 2026 4:07 PM - StreetInsider
Form 8-K AMGEN INC For: Jul 29
July 31, 2026 4:04 PM - SEC Filing
Amgen (AMGN) call put ratio 3.8 calls to 1 put with a focus on July 31 weekly calls into quarter results
July 31, 2026 11:03 AM - StreetInsider
Amgen (AMGN) Declares $2.52 Quarterly Dividend; 2.6% Yield
July 30, 2026 4:02 PM - StreetInsider
AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND
July 30, 2026 4:01 PM - PR NewsWire
Amgen (AMGN) PT Raised to $360 at Barclays
July 29, 2026 5:19 AM - StreetInsider
AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS
July 28, 2026 4:45 PM - PR NewsWire
Amgen (AMGN) PT Raised to $343 at Guggenheim
July 13, 2026 6:51 AM - StreetInsider
Amgen (AMGN) PT Raised to $312 at BofA Securities
July 13, 2026 5:38 AM - StreetInsider
Amgen (AMGN) PT Lowered to $333 at Morgan Stanley
July 8, 2026 8:07 AM - StreetInsider
Amgen (AMGN) PT Raised to $340 at Truist Securities
July 7, 2026 7:08 AM - StreetInsider
Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald: Q2 Beat Expected
July 6, 2026 6:49 AM - StreetInsider
BMO Capital Reiterates Outperform Rating on Amgen (AMGN)
July 1, 2026 8:48 AM - StreetInsider
Agility Robotics to go public via $2.5B SPAC merger
June 24, 2026 6:00 AM - StreetInsider
Agility Robotics to Go Public Through $2.5 Billion Merger with Churchill Capital Corp XI
June 24, 2026 6:00 AM - BizWire
Amgen (AMGN) PT Raised to $303 at Mizuho
June 16, 2026 6:40 AM - StreetInsider
Piper Sandler Reiterates Overweight Rating on Amgen (AMGN)
June 12, 2026 8:25 AM - StreetInsider
Form 11-K AMGEN INC For: Dec 31
June 11, 2026 4:24 PM - SEC Filing
Form 11-K AMGEN INC For: Dec 31
June 11, 2026 4:22 PM - SEC Filing
Amgen (AMGN) PT Raised to $340 at Morgan Stanley
June 9, 2026 4:37 PM - StreetInsider
AMGEN's Repatha shows 29% cardiovascular event reduction in diabetes study
June 8, 2026 2:56 AM - StreetInsider
Full Article List
